Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) |
|---|---|
| Disease/Condition | Lung Cancer |
| Description | |
| Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
| Principal Investigator | Steven Keller, MD |
| Contact Name | Alexandra Urman |
| Phone | (718) 379-6868 |
| Contact Email | aurman@montefiore.org |
| Protocol Number | IRB# 2016-7018 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
